Researcher
Oliver Bechter
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From7 May 2012 → Today
Projects
1 - 5 of 5
- Dissecting the heterotypic cell communication networks at the perivascular niche to detect andintercept the early metastatic processFrom1 Jan 2023 → TodayFunding: BOF - iBOF
- Multiplexed immunohistochemistry and digital pathology as the foundation for next-generation pathology in melanoma researchFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation pathology by MILAN: multiplex immunohistochemistry and advanced trainable image analysisFrom1 Jan 2020 → 31 Dec 2021Funding: IOF - technology validation in lab
- Preventing therapy-induced cancer stemnessFrom1 Oct 2019 → TodayFunding: IOF - technology concept exploration, BOF - projects
- Treating melanoma as an infectious diseaseFrom1 Sep 2018 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
Publications
11 - 20 of 81
- [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients(2023)
Authors: Sofie Celen, Kristof Baete, Michel Koole, Oliver Bechter, Paul Clement, Koen Van Laere, Guy Bormans, Christophe Deroose
Pages: 1134 - 1145 - SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response(2022)
Authors: Ewout Landeloos, Yannick Van Herck, Oliver Bechter, Chris Marine
- Melanoma cell plasticity poses diagnostic challenges: a case series(2022)
Authors: Yannick Van Herck, Raf Sciot, Isabelle Vanden Bempt, Veerle Boecxstaens, Maria Garmyn, Oliver Bechter
Pages: 428 - 439 - Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy (vol 22, pg 108, 2021)(2022)
Authors: Jenny Sprooten, Oliver Bechter, Sabine Tejpar, Abhishek Garg
Pages: 260 - 260 - A cellular hierarchy in melanoma uncouples growth and metastasis (vol 610, pg 190, 2022)(2022)
Authors: Panagiotis Karras, Joanna Poźniak, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, Joost van den Oord, et al.
Pages: E4 - E4 - Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors(2022)
Authors: Yuling Yu, Beatrice Santens, Johanna Jacobs, Benoit Beuselinck, Oliver Bechter, Els Wauters, Jan A Staessen, Lucas Van Aelst
Pages: 3430 - + - A cellular hierarchy in melanoma uncouples growth and metastasis(2022)
Authors: Panagiotis Karras, Ada Nowosad, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Dennis Pedri, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, et al.
Pages: 190 - + - Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response(2022)
Authors: Yannick Van Herck, Veerle Boecxstaens, Chris Marine, Joost van den Oord, Frederik De Smet, Oliver Bechter, Francesca Bosisio
Pages: 3275 - 3290 - Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population(2022)
Authors: Julie De Smedt, Laudine Janssen, Veerle Boecxstaens, Dirk Vanderschueren, Kris Bogaerts, Katleen Vandenberghe, Oliver Bechter, Diether Lambrechts, Maria Garmyn
- Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer(2022)
Authors: Ward Celus, Silvia Rivis, Ewout Landeloos, Yannick Van Herck, Abhishek Garg, Chris Marine, Mario di Matteo, Oliver Bechter, Max Mazzone
Pages: 126 - 141